CAZZANIGA, GIULIA
CAZZANIGA, GIULIA
Dipartimento di Scienze Farmaceutiche
Γ-HYDROXY LACTONE AS A VERSATILE SCAFFOLD FOR THE DEVELOPMENT OF NOVEL BIOACTIVE COMPOUNDS
2024 G. Cazzaniga
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Synthesis and Analytical Characterization of Cyclization Products of 3-Propargyloxy-5-benzyloxy-benzoic Acid Methyl Ester
2024 M. Mori, G. Cazzaniga, D. Nava, E. Pini
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
2024 M. Mori, M. Cocorullo, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G.F. Mangiatordi, M. Garofalo, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids
2024 G. Cazzaniga, A. Tresoldi, A. Gelain, F. Meneghetti, M. Mori, S. Villa
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria
2023 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Discovery of novel SIRT5 activators as potential anti-inflammatory agents
2023 A. Gelain, . Mori, G. Cazzaniga, F. Meneghetti, . Wong, L. Jun Yan, P.S. Coghi, S. Villa
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB
2023 M. Mori, G. Cazzaniga, A. Tresoldi, A. Gelain, L.R. Chiarelli, G. Stelitano, M. Bellinzoni, S. Villa, F. Meneghetti
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, M. Quaglia, G. Grazioso, F. Meneghetti, S. Villa
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition
2023 D. Capelli, G. Cazzaniga, M. Mori, A. Laghezza, F. Loiodice, M. Quaglia, E. Negro, F. Meneghetti, S. Villa, R. Montanari
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
2023 M. Mori, G. Stelitano, G. Cazzaniga, A. Gelain, A. Tresoldi, M. Cocorullo, M. Roversi, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G. Felice Mangiatordi, A. Griego, L. Rizzello, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors
2022 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, G. Cazzaniga, M. Bellinzoni, L. Rizzello, E. Scarpa, A. Griego, A. Fumagalli, F. Meneghetti
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity
2022 G. Cazzaniga, M. Mori, F. Meneghetti, L.R. Chiarelli, G. Stelitano, C. Di Gugliemo, I.L. Batalha, G. Battaglia, S. Villa
Polymersomes as selective drug delivery carriers for innovative anti-TB agents
2022 G. Cazzaniga, M. Mori, F. Meneghetti, L.R. Chiarelli, G. Stelitano, I.L. Batalha, G. Battaglia, S. Villa
γ-lactone derivatives: a new promising class of protein tyrosine phosphatase B (MptpB) inhibitors as anti-TB agents
2022 G. Cazzaniga
Development of a novel approach to overcome biofilm formation by natural product derivatives
2022 A. Gelain, G. Cazzaniga, M. Mori, P.J. Molino, P. Hajes, F. Villa, C. Cattò, F. Cappitelli, S. Villa
New strategies to overcome biofilm formation by natural product derivatives
2022 S. Villa, G. Cazzaniga, M. Mori, P.J. Molino, P. Hayes, F. Villa, C. Cattò, F. Cappitelli, A. Gelain
Methyl 5-(2-Fluoro-4-nitrophenyl)furan-2-carboxylate
2022 M. Mori, A. Tresoldi, G. Cazzaniga, F. Meneghetti, S. Villa